Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€83.00
22.12.19
€79.00
04.11.21
-3.61%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€76.60
20.11.19
€85.00
04.11.21
4.44%
05.11.21

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€77.60
06.10.19
€90.00
04.11.21
3.09%
05.11.21

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€235.41
17.01.19
€419.00
04.11.21
67.81%
05.11.21

Could be worthwhile Investment >10% per year
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€71.50
01.03.19
€77.00
04.11.21
-1.04%
26.10.21

Could be worthwhile Investment >10% per year
Pfizer Inc.

Start price
Target price
Perf. (%)
€39.50
28.08.21
-
28.08.22
0.10%
04.09.21

Risky Investment
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.50
30.11.20
€38.00
30.11.21
18.40%
02.08.21

Could be worthwhile Investment >10% per year
Very high dividend yield expected
Fair valuation
Higher EBIT margin than peer group
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.31
09.07.21
-
09.07.22
0.27%
09.07.21

Top 10 in its market
Small cyclical dependencies
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.93
04.08.20
€38.00
04.11.21
0.31%
13.04.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€136.62
24.03.21
€145.00
24.03.22
-1.26%
09.04.21

Known brand
Future proof or reliable business model
Medium risks for its business
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€138.90
05.02.21
-
31.12.21
0.09%
29.03.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€35.01
12.12.20
-
12.12.21
-14.23%
24.03.21

Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.01
18.12.20
€34.00
18.12.21
-5.35%
15.03.21

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€134.68
20.01.21
€144.00
0.89%
02.02.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.91
17.12.20
€29.00
-1.81%
21.12.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.30
09.11.20
€37.95
-11.94%
17.12.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.31
16.11.20
-
5.61%
11.12.20

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€28.65
12.07.20
-
17.10.20
9.93%
17.10.20

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€264.80
05.06.20
€290.00
12.10.20
5.70%
12.10.20

Pfizer Inc.

Start price
Target price
Perf. (%)
€30.93
25.08.20
€25.62
03.09.20
-2.45%
03.09.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.70
16.07.20
€33.21
25.08.20
4.15%
25.08.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€28.84
01.07.20
€42.69
08.07.20
-2.30%
08.07.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€124.68
01.03.19
€130.79
11.03.20
-5.54%
11.03.20

Could be worthwhile Investment >10% per year
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€224.77
25.06.19
€270.60
06.09.19
-7.88%
06.09.19

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€216.11
10.03.19
€239.03
12.07.19
10.11%
12.07.19

Could be worthwhile Investment >10% per year